Table 2

Procedural Characteristics

TAVR
 Procedural success139/142 (97.9)
 Total procedure time, min90.3 ± 38.6
 Local anesthesia26/142 (18.3)
 Use of inotropes86/142 (60.6)
 Implantation of >1 valve prosthesis4/142 (2.8)
 Conversion to surgery3/142 (2.1)
 Transfemoral access137/142 (96.5)
 Transsubclavian access5/142 (3.5)
 Valve size implanted
 23 mm2/142 (1.4)
 26 mm57/142 (40.1)
 29 mm69/142 (48.6)
 31 mm14/142 (9.9)
SAVR
 Total procedure time, min177.2 ± 39.8
 Conversion to other procedure2/134 (1.5)
 Use of inotropes48/133 (36.1)
 Valve size implanted
 19 mm11/132 (8.3)
 21 mm42/132 (31.8)
 23 mm45/132 (34.1)
 25 mm32/132 (24.2)
 27 mm2/132 (1.5)

Values are n/N (%) or mean ± SD.

Abbreviations as in Table 1.

  • Defined as leaving the catheterization room with a functional transcatheter self-expanding prosthesis.

  • 1 apico-aortic conduit and 1 apical TAVR with a balloon-expandable bioprosthesis.